CROI 2022

12 - 16, 22, 23 and 24 February 2022

The Conference on Retroviruses and Opportunistic Infections (CROI) was again one of the most eagerly anticipated HIV events of the year. Bringing together the most respected infectious disease healthcare professionals and researchers from around the globe, CROI remains one of the world’s most prestigious congresses in this field.

For the last two years, the congress has been a 100% virtual event and we’re all looking forward to connecting in person again soon. Virtual or not, CROI 2022 offered a fantastic platform to discuss the latest advancements and discoveries in HIV research.

In the current climate, CROI 2022’s focus on human retroviruses and infectious diseases made this year’s congress more important than ever. ViiV Healthcare was delighted to present data that reinforces our leadership and commitment to developing innovative new approaches to treatment and care for people living with or affected by HIV.

As always, the CROI programme included some important key topics, such as: 

  • Progress in HIV treatment and prevention
    CROI 2022 was a great place to discuss and see emerging science and advances in treatment and prevention. The breakthroughs shared at CROI 2022 will help us to reach, and better support, a wider group of people living with and affected by HIV.
  • HIV and ageing
    ViiV exists to serve all those in the community and there is a growing ageing population requiring our focus and attention. Although advances in treatment have dramatically improved the life expectancy of people living with HIV, challenges remain for those ageing with it. CROI was a real opportunity to explore potential solutions so that we leave no person living with HIV behind.
  • HIV cure
    These advances in care and treatment options all contribute to the overall goal of finding an HIV cure. ViiV is here until HIV and AIDS are not, so at CROI 2022, as ever, we continued to look out for the progress being made in the overall fight to end the HIV epidemic.

Why is collaboration critical to finding a cure? Discover more about our commitments and partnerships.

What challenges are people ageing with HIV facing? Learn about the research we’re undertaking to better support them.

Can we make progress faster? Learn how we’re developing new innovative medicines quicker than ever before.

For people living with HIV. Resources and information about living well with HIV.

For news and media. Latest news and press releases via our media centre.

For healthcare professionals, Information about ViiV medicines and data.


Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at or search for MHRA Yellowcard in the Google Play or Apple App store. By reporting side effects, you can help provide more information on the safety of this medicine.

If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.